Acorda Loses Patent Fight Over Apotex's Generic Zanaflex
A New Jersey federal judge ruled on Tuesday that Apotex Inc.'s proposed generic version of the muscle-relaxing drug Zanaflex did not infringe Acorda Therapeutics Inc.'s patent, and that the patent was...To view the full article, register now.
Already a subscriber? Click here to view full article